Adalimumab Therapy Achieves Clinical Remission and Response at Week 26 in Chinese Patients with Crohn's Disease

被引:1
|
作者
Wu, Kai-Chun [1 ]
Ran, Zhi Hua [2 ]
Gao, Xiang [3 ]
Chen, Minhu [4 ]
Zhong, Jie [5 ]
Sheng, Jian-Qiu [6 ]
Kamm, Michael A. [7 ,8 ]
Travis, Simon [9 ,10 ]
Robinson, Anne M.
Wallace, Kori
Shapiro, Marisa
Li, Yao
Thakkar, Roopal B.
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Xian, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Renji Hosptial, Huangpu, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[5] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China
[6] Beijing PLA, Mil Gen Hosp, Beijing, Peoples R China
[7] St Vincents Hosp Melbourne, Parkville, Vic, Australia
[8] Univ Melbourne, Parkville, Vic, Australia
[9] John Radcliffe Hosp, Oxford, England
[10] AbbVie Inc, N Chicago, IL USA
关键词
D O I
10.1097/01.MIB.0000480212.77049.85
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P-107
引用
收藏
页码:S43 / S43
页数:1
相关论文
共 50 条
  • [21] Maintenance of the Remission Stage of Crohn's Disease with Adalimumab Therapy during Pregnancy
    Mizoshita, Tsutomu
    Tanida, Satoshi
    Tsukamoto, Hironobu
    Ozeki, Keiji
    Katano, Takahito
    Ebi, Masahide
    Mori, Yoshinori
    Kataoka, Hiromi
    Kamiya, Takeshi
    Joh, Takashi
    INTERNAL MEDICINE, 2013, 52 (10) : 1049 - 1053
  • [22] Rapid induction of remission and clinical response with adalimumab in patients with moderate to severe Crohn's disease and secondary failure to infliximab therapy: Results of the gain studya
    Columbel, J.
    Rutgeerts, P.
    Sandborn, W. J.
    Enns, R.
    Hanauer, S. B.
    Kent, J. D.
    Pollack, P. F.
    GUT, 2007, 56 : A109 - A109
  • [23] Comparative study of infliximab and adalimumab induction therapy for clinical remission and mucosal healing in paediatric patients with active Crohn's disease
    Szymanska, E.
    Dadalski, M.
    Szymanska, S.
    Grajkowska, W.
    Pronicki, M.
    Jaroslaw, K.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S290 - S290
  • [24] Optimizing Response to Certolizumab Pegol Therapy in Crohn's Disease: A 26-Week Study
    Wolf, Douglas C.
    Wolf, Christine H.
    GASTROENTEROLOGY, 2012, 142 (05) : S788 - S788
  • [25] Endoscopic healing and clinical remission after administration of adalimumab to patients with Crohn's disease of the small intestine
    Viazis, N.
    Koustenis, K.
    Veretanos, C.
    Mountaki, A.
    Almpani, F.
    Tsatsa, A.
    Trikola, A.
    Beka, H.
    Arvanitis, K.
    Georgiadi, T.
    Nousias, G.
    Mylonas, I.
    Kozompoli, D.
    Paparizou, N.
    Karaouzas, L.
    Papastergiou, V.
    Archavlis, E.
    Mela, M.
    Christidou, A.
    Varytimiadis, K.
    Hatzievangelinou, C.
    Katopodi, K.
    Vienna, E.
    Mantzaris, G.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 840 - 840
  • [26] Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series
    Cordero Ruiz, Patricia
    Castro Marquez, Cristina
    Mendez Rufian, Vanesa
    Castro Laria, Luisa
    Caunedo Alvarez, Angel
    Romero Vazquez, Javier
    Herrerias Gutierrez, Juan Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2011, 103 (06) : 294 - 298
  • [27] Cost-effectiveness of adalimumab for the maintenance of remission in patients with Crohn's disease
    Loftus, Edward V., Jr.
    Johnson, Scott J.
    Yu, Andrew P.
    Wu, Eric Q.
    Chao, Jingdong
    Mulani, Parvez M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (11) : 1302 - 1309
  • [28] Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on adalimumab maintenance therapy
    Oh, E. H.
    Yoon, A. -R.
    Park, S. H.
    Kim, J.
    Ham, N.
    Song, E. M.
    Hwang, S. W.
    Park, S. H.
    Yang, D. -H.
    Byeon, J. -S.
    Myung, S. -J.
    Yang, S. -K.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S260 - S261
  • [29] Microinflammation in patients with Crohn's disease in clinical remission
    Maharshak, Nitsan
    Zilberman, Liaz
    Arbel, Yaron
    Shapira, Itzhak
    Berliner, Shlomo
    Arber, Nadir
    Dotan, Iris
    JOURNAL OF CROHNS & COLITIS, 2008, 2 (04): : 310 - 314
  • [30] Rates of Clinical Response, Clinical Remission and Endoscopic Response in Crohn's Disease: Monotherapy Versus Combined Therapy
    Bruna, Moutinho
    Julio, Baima
    Rogerio, Saad-Hossne
    Ligia, Sassaki
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S19 - S19